CONMED (CNMD) Stock Price, News & Analysis

Company Overview

CONMED Corporation (NYSE: CNMD) is a medical technology company that develops, manufactures and markets products used in minimally invasive surgical procedures. Its offerings support healthcare providers across a range of specialties, including general surgery, gastroenterology, pulmonology, gynecology, orthopedics and sports medicine.

The company’s products include advanced surgical devices and systems, electrosurgical equipment, smoke evacuation systems, endoscopic instruments, powered surgical tools, and orthopedic products used in arthroscopic and reconstructive procedures. CONMED markets products under brands such as AirSeal and Linvatec, serving hospitals, ambulatory surgery centers and other healthcare facilities.

Founded in 1970, CONMED serves customers in the United States and international markets through a combination of direct sales and distributor relationships. The company is headquartered in Largo, Florida, and has built its business around providing technologies designed to assist surgeons and improve procedural efficiency and patient care.

Key Stats

• Today's Range: $45.89 to $47.06
• 50-Day Range: $44.22 to $51.52
• 52-Week Range: $31.44 to $53.66
• Volume: 342,338 shs
• Average Volume: 381,530 shs
• Market Capitalization: $1.38 billion
• P/E Ratio: 24.96
• Dividend Yield: N/A
• Price Target: $41.40
• Consensus Rating: Reduce

CONMED Stock Analysis - MarketRank™

CONMED scored higher than 31% of companies evaluated by MarketBeat, and ranked 749th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Reduce

Consensus Rating

CONMED has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no strong buy ratings, no buy ratings, 6 hold ratings, and 2 sell ratings.

Downside Risk

CONMED has a consensus price target of $41.40, representing about 10.3% downside from its current price of $46.18.

Amount of Analyst Coverage

CONMED has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.19%

Earnings Growth

Earnings for CONMED are expected to grow by 4.19% in the coming year, from $4.54 to $4.73 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CONMED is 24.96, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 35.60.

Price to Earnings Ratio vs. Sector

The P/E ratio of CONMED is 24.96, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 201.95.

Price to Earnings Growth Ratio

CONMED has a PEG Ratio of 2.13. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

CONMED has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.55% of the float of CONMED has been sold short.

Short Interest Ratio / Days to Cover

CONMED has a short interest ratio ("days to cover") of 5.23.

Change versus previous month

Short interest in CONMED has recently decreased by 8.52%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: N/A

Dividend Yield

CONMED does not currently pay a dividend.

Dividend Growth

CONMED does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, CONMED will have a dividend payout ratio of 12.68% next year. This indicates that CONMED will be able to sustain or increase its dividend.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CONMED insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.28% of the stock of CONMED is held by insiders.

Percentage Held by Institutions

CONMED has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 10/19/2026
• Next Earnings (Confirmed): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:CNMD
• CIK: 816956
• Web: www.conmed.com
• Phone: (727) 392-6464
• Fax: 315-797-0321
• Employees: 3,900
• Year Founded: 1970

Price Target and Rating

• Average Price Target for CONMED: $41.40
• High Price Target: $46.00
• Low Price Target: $36.00
• Potential Upside/Downside: -10.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.75
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.85
• Trailing P/E Ratio: 24.96
• Forward P/E Ratio: 10.17
• P/E Growth: 2.13
• Net Income: $47.06 million
• Net Margins: 4.12%
• Pretax Margin: 6.07%
• Return on Equity: 14.31%
• Return on Assets: 6.33%

Debt

• Debt-to-Equity Ratio: 0.63
• Current Ratio: 1.48
• Quick Ratio: 0.69

Sales & Book Value

• Annual Sales: $1.37 billion
• Price / Sales: 1.01
• Cash Flow: $7.12 per share
• Price / Cash Flow: 6.49
• Book Value: $33.36 per share
• Price / Book: 1.38

Miscellaneous

• Outstanding Shares: 29,950,000
• Free Float: 29,867,000
• Market Cap: $1.38 billion
• Optionable: Optionable
• Beta: 0.94